References
- Jeffries G. H. Protein losing gastroenteropathy. Gastrointestin. Disease, M. H. Sleisenger, J. S. Ford-Tran. W.B. Saunders Company, Philadelphia 1989; 283–290
- Waldmann T. A., Strober W., Blaese R. M. Immunodeficiency disease and malignancy. Ann. Intern. Med. 1972; 77: 605–628
- Ward M., Roux A. L., Small W. P., Sircus W. Malignant lymphoma and extensive viral wart formation in a patient with intestinal lymphangiectasia and lymphocyte depletion. Postgrad. Med. J. 1977; 53: 753–757
- Case Records of the Massachusetts General Hospital (case 8–1984). N. Engl. J. Med. 1984; 310: 512–520
- Broder S., Callihan T. R., Jaffe E. S., Devita V. T., Strober W., Bartter F. C., Waldrnann T. A. Resolution of longstanding protein-losing enteropathy in a patient with intestinal lymphangiectasia after treatment for malignant lymphoma. Gastroenterology 1981; 80: 166–168
- Filipovich A. H., Shapiro R., Robison L., Mertens A., Frizzera G. Lymphoproliferative disorders associated with immunodeficiency. The Non-Hodgkin's Lymphomas, T. Ian Magrath. Edward Arnold, London 1990; 135–154
- Sorensen R. U., Halpin T. C., Abramowsky C. R., Hor-Nick D. L., Miller K. M., Naylor P., Incefy G. S. Intestinal lymphangiectasia and thymic hypopkdsia. Clinic. Experiment. Immunol. 1985; 59: 217–226
- Fleisher T. A., Strober W., Muchmore A. V., Broder S., Krawitt E. L., Waldmann T. A. Corticosteroid— responsive intestinal lymphangiectasia secondary to an inflammatory process. N. Engl. J. Med. 1979; 300: 605–606
- Cohen S. A., Diuguid D. L., Whitlock R. T., Holt P. R. Intestinal lymphangiectasia and antiplasmin therapy. Gastroenterology 1992; 102: 2193